147 related items for PubMed ID: 11449531
1. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A.
Allergol Immunopathol (Madr); 2001; 29(1):22-7. PubMed ID: 11449531
[Abstract] [Full Text] [Related]
2. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
3. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I.
Allergol Immunopathol (Madr); 1999 Jul; 27(6):298-303. PubMed ID: 10611554
[Abstract] [Full Text] [Related]
4. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.
Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL.
Am J Respir Crit Care Med; 1996 Mar; 153(3):924-30. PubMed ID: 8630574
[Abstract] [Full Text] [Related]
5. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
6. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[Abstract] [Full Text] [Related]
7. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
8. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
9. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
10. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P.
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[Abstract] [Full Text] [Related]
11. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP, Dahl R.
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[Abstract] [Full Text] [Related]
12. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density.
Hughes JA, Conry BG, Male SM, Eastell R.
Thorax; 1999 Mar; 54(3):223-9. PubMed ID: 10325897
[Abstract] [Full Text] [Related]
13. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
14. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.
J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
[Abstract] [Full Text] [Related]
15. Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate.
Berend N, Kellett B, Kent N, Sly PD, Collaborative Study Group of the Australian Lung Foundation.
Respirology; 2001 Sep; 6(3):237-46. PubMed ID: 11555383
[Abstract] [Full Text] [Related]
16. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[Abstract] [Full Text] [Related]
17. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Jan; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
18. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
19. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
20. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.
Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.
Thorax; 2004 Jan; 59(1):26-30. PubMed ID: 14694242
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
